Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial cell apoptosis refers to the programmed cell death of IECs, a crucial mechanism for maintaining the homeostasis, integrity, and renewal of the gut barrier. Apoptosis allows for the recognition and silent removal of senescent or damaged cells without triggering inflammation, facilitates immune tolerance in the gut, and is balanced with cell division to preserve tissue architecture. Dysregulation of this process contributes to several diseases, notably inflammatory bowel disease, where excessive or insufficient IEC apoptosis is linked to barrier dysfunction and pathogenic inflammation. While apoptosis in IECs involves common molecular mediators like caspase-3, caspase-7, and TNF pathways, it is itself not a discrete molecular target but an endpoint influenced by various upstream signals and therapeutic interventions
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal epithelial cell apoptosis.